Stockreport

Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF - Top-line results from the Phase 2 RADIANT study of remlifanserin (formerly ACP-204) in Alzheimer's disease psychosis anticipated between August and October 2026 - U [Read more]